BioPlus Acquisition Corp.
BIOS · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $261 | $246 | $6,109 | $295 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $5 | $5 | $5 | $5 |
| Enterprise Value | $266 | $251 | $6,114 | $299 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$1 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | $1 | $2 | $2 | $1 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.05 | 0.17 | 0.06 | 0.02 |
| % Growth | -70.6% | 185.7% | 197.5% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |